Elite Pharmaceuticals launches generic methadone tablets; addresses $22M market

ELITE PHARMACEUTICALS INC /NV/

Launched generic methadone HCl 5 mg and 10 mg tablets under Elite Laboratories label.
Product indicated for severe persistent pain and opioid addiction detoxification/maintenance treatment.
Annual retail sales for brand and generic methadone tablets approx. $22M (IQVIA 2025 data).
Company operates a cGMP and DEA-registered R&D and manufacturing facility in Northvale, NJ.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.